16-hydroxyandrost-4-en-3,17-dione has been researched along with Diseases of Endocrine System in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernhardt, R; Hartmann, MF; Khatri, Y; Milhim, M; Neunzig, J; Sánchez-Guijo, A; Schiffer, L; Wudy, SA; Zapp, J | 1 |
1 other study(ies) available for 16-hydroxyandrost-4-en-3,17-dione and Diseases of Endocrine System
Article | Year |
---|---|
The steroid metabolite 16(β)-OH-androstenedione generated by CYP21A2 serves as a substrate for CYP19A1.
Topics: Androgens; Androstenedione; Aromatase; Aromatase Inhibitors; Catalysis; Child, Preschool; Crystallography, X-Ray; Dose-Response Relationship, Drug; Endocrine System; Endocrine System Diseases; Escherichia coli; Estrogen Receptor alpha; Female; Humans; Kinetics; Magnetic Resonance Spectroscopy; Receptors, Androgen; Recombinant Proteins; Spectrophotometry, Ultraviolet; Steroid 21-Hydroxylase; Steroids | 2017 |